Advanced Enzyme Technologies Limited, a leading specialty biotech company, with global leadership in the manufacturing of enzymes, announced unaudited financial results for second quarter ended September 2017.
Financial Highlights – Q2FY18 vs Q2FY17:
Consolidated Q2FY18 Sales (net of excise duty) up 9% YoY to INR 986 mn against Rs. 904 mn in Q2FY17
Consolidated EBITDA for Q2FY18 stands at Rs. 414 mn against Rs. 487 mn in Q2FY17, down 15%
Consolidated EBITDA Margin for Q2FY18 stands at 42% as against 52% in Q2FY17
Consolidated Q2FY18 Net Profit down 23% at Rs. 224 mn against Rs. 291 in Q2FY17